31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis

31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis | ECTRIMS 2015

ECTRIMS 2015 "is one of the most important and powerful concentrations of MS professionals world-wide and constitutes a chance for bottomline networking and collaboration opportunities." The conference will be "a four-day vibrant and intensive scientific meeting with many learning opportunities in every current aspect of MS."

Conference Coverages

Q&A With Helen Tremlett From the University of British Columbia: Gut Microbiome And Its Role In Multiple Sclerosis
Q&A With Helen Tremlett From the University of British Columbia: Gut Microbiome And Its Role In Multiple Sclerosis VIDEO
The guy microbiome is being studied across the healthcare spectrum as more is learned about this part of a person's anatomy. What it could mean for the treatment of multiple sclerosis has yet to be determined.
Q&A With Mauricio Farez From the FLENI Foundation: Melatonin's Role In Multiple Sclerosis Relapse VIDEO
There are many factors that can contribute to a person's condition with multiple sclerosis. A recent study looked at what role melatonin can play in the process.
Q&A With June Halper From CMSC: Taking Global Lessons To Improve Multiple Sclerosis Care Worldwide And At Home VIDEO
Earlier this year the Consortium of Multiple Sclerosis Centers held its annual conference in Indianapolis with more than 2000 people in attendance. All with the same goal of improving the care they provide their patients with this difficult disease.
Q&A With Deborah Miller From Cleveland Clinic: Measuring Quality of Life Issues In Patients With Multiple Sclerosis VIDEO
There are many factors that patients diagnosed with multiple sclerosis need to consider when managing their condition. While the physical symptoms can be the highest priority, quality of life is an area which is gaining greater recognition in the field.
Q&A With Kate Dawson From Biogen: Tecfidera Continues To Show Positive Results For Multiple Sclerosis Patients VIDEO
Tecfidera has been on the market for a few years to help treat relapsing remitting multiple sclerosis and through extended studies and watching the market positive results have been seen by patients using the oral treatment.
Q&A With Paulo Fontura From Roche: Ocrelizumab Shows First Signs of Promise For Patients With Primary Progressive Multiple Sclerosis VIDEO
Even as more medications are developed for relapsing remitting multiple sclerosis patients those with the primary progressive form have been left waiting for news on their condition. According to recent studies the first step in that process may soon be coming to the market.
Q&A With Bernd Kieseier From Biogen: MS Paths Looks To Streamline Multiple Sclerosis Treatment For Doctors, Patients VIDEO
With doctors having to take on more administrative work in addition to their patient care duties finding systems that can help them accomplish their goals without adding more time consuming tasks can be crucial.
Q&A With Luca Prosperini From Sapienza University: Improving Multiple Sclerosis Treatment Through Medication And Video Games VIDEO
Newer medications for the treatment of multiple sclerosis have been developed in recent years but for some patients interferon remains the starting point for pharmaceutical options.
Q&A With Carrie Lyn Sammarco From NYU Langone Medical Center: Addressing Quality of Life Issues With Multiple Sclerosis Through Medication And The Benefits of Teamwork VIDEO
Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. At the NYU Langone Medical Center Comprehensive Care Center patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$